J.P. Morgan Sees Sangamo Biosciences, Inc. As Attractive Investment Opportunity
September 09, 2014 at 09:20 AM EDT
In a report published Tuesday, J.P. Morgan analyst Cory Kasimov reiterated an Overweight rating and $22.00 price target on Sangamo ...